Overall clinical and economic impact of non-alcoholic fatty liver disease.
Antoni Sicras-MainarRocio AllerJavier CrespoJosé Luis CallejaJuan TurnesManuel Romero GómezSalvador AugustínPublished in: Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva (2021)
patients with advanced fibrosis were associated with more comorbidity and concomitant medications, which resulted in higher healthcare costs for the National Health System.